SWAG视频

BA Biochemistry 1986
University of California, Berkeley

PharmD 1990
University of California, San Francisco

Residency

Oncology 1992 National Institutes of Health Clinical Center, Bethesda, Maryland

Board Certified Oncology Pharmacist (BCOP), Board of Pharmaceutical Specialties

Board Certified Pharmacotherapy Specialist (BCPS), Board of Pharmaceutical Specialties

City of Hope National Medical Center
1500 East Duarte Road
Duarte, California 91010

Clinical Experience Rotation: Students will work with the supportive care medicine consult service and assist with the management of patients with cancer and/or cancer therapy-related symptoms. A multidisciplinary approach towards patient care will provide the student with the opportunity to interact with patients, physicians, nurses, pharmacists, and other health care personnel.

Research Experience Rotation: Students will gain clinical research experience by designing retrospective research study protocols, collecting and analyzing data, preparing original research or literature review manuscripts for publication, and peer-reviewing abstracts and publications.

Principal Investigator, 鈥淢aking Rx Drug Abuse Extinct鈥�, American Medical Association Foundation Healthy Living Grant, 2015

Prinicipal Investigator, 鈥淏e Smart 鈥� Be Safe in the Sun鈥�, California Dialogue on Cancer/Public Health Initiative, 2012

Chan A, Hertz DL, Morales M, Adams EJ, Gordon S, Tan CJ, Staff NP, Kamath J, Oh J, Shinde S, Pon D, Dixit N, D'Olimpio J, Dumitrescu C, Gobbo M, Kober K, Mayo S, Pang L, Subbiah I, Beutler AS, Peters KB, Loprinzi C, Lustberg MB. Biological Predictors of Chemotherapy-induced Peripheral Neuropathy (CIPN): MASCC Neurological Complications Working Group Overview.

Kieu V, Jhangiani K, Dadwal S, Nakamura R, Pon D. 鈥淓ffect of Isavuconazole on Tacrolimus and Sirolimus Serum Concentrations in Allogeneic Hematopoietic Stem Cell Transplant Patients: A Drug-Drug Interaction Study.

Davies M, Pon D, Garavalia LS. 鈥淚mproving Pharmacy Calculations Using an Instructional Design Model.鈥�

Pon D, Awuah K, Curi D, Okyere E, Stern CS. 鈥淐ombating an Epidemic of Prescription Opioid Abuse.鈥� California Pharmacist 2016;63:23-31.

Pon D, Hwang J, Lo T, Van Zyl C. 鈥淒ecreased Responsiveness to Oxycodone: A Case of a Pharmacokinetic Drug Interaction?鈥� J Opioid Manag 2015;11(4):357-361. DOI: 10.5055/jom.2015.0284.

Cho E, Chan H, Nguyen H, Shayani S, Nakamura R, Pon D. 鈥淢anagement of Drug Interaction between Posaconazole and Sirolimus in Patients Who Undergo Hemaatopoietic Stem Cell Transplant.鈥� Pharmacotherapy 2015;35:578-85.

Pon D, Abe A, Gupta E. 鈥淎 Review of Statin Use and Prostate Cancer.鈥� Curr Atheroscler Rep 2015;17:474.